Cravath’s New York Office Moves to Two Manhattan West
Aaron M. Gruber is Co-Head of the Global Mergers and Acquisitions Practice. He focuses his practice on mergers and acquisitions, activist defense, corporate governance and general corporate matters.
Mr. Gruber’s clients have included Alcoa, Assisted Living Concepts, Barrick Gold, BDT, Biogen, Biovail Pharmaceuticals, Cigna, Corteva, Cowen, Deutsche Börse, Element Financial, Eurazeo, FS Investments, KION Group, Knorr‑Bremse, The Linde Group, Novartis, NRG Energy, RELX Group, RWE, Ulta Beauty, Unilever, Viatris and Vista Outdoor.
Notable transactions include representing:
Mr. Gruber has been recognized for his work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000 and Lawdragon and has also been recognized by The Legal 500 US for his transactional work in the technology industry. He was named to Bloomberg Law’s “40 Under 40” list in 2022 and was named a “Dealmaker of the Year” by The American Lawyer magazine in 2018. In 2019, he received Euromoney Legal Media Group’s Americas Rising Star Award for “Best in Mergers & Acquisitions,” as well as a “Deal of the Year” award in recognition of his work on behalf of Linde in its $70 billion merger of equals with Praxair. Mr. Gruber’s work on this transaction was also featured by the Financial Times in its annual FT North America Innovative Lawyers 2018 report. In 2018 and 2019, he was selected to serve as a member of Law360’s Mergers & Acquisitions Editorial Advisory Board. Mr. Gruber also presents on developments in corporate and mergers and acquisitions law, having participated in events such as TechGC’s Global Summit.
Mr. Gruber was raised in Newport Beach, California. He received a B.S. summa cum laude from Yale College and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar. He received a J.D. from Stanford Law School, where he was elected to the Order of the Coif.
Mr. Gruber joined Cravath in 2007 and was elected a partner in 2014.
Notable transactions include representing:
Mr. Gruber has been recognized for his work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000 and Lawdragon and has also been recognized by The Legal 500 US for his transactional work in the technology industry. He was named to Bloomberg Law’s “40 Under 40” list in 2022 and was named a “Dealmaker of the Year” by The American Lawyer magazine in 2018. In 2019, he received Euromoney Legal Media Group’s Americas Rising Star Award for “Best in Mergers & Acquisitions,” as well as a “Deal of the Year” award in recognition of his work on behalf of Linde in its $70 billion merger of equals with Praxair. Mr. Gruber’s work on this transaction was also featured by the Financial Times in its annual FT North America Innovative Lawyers 2018 report. In 2018 and 2019, he was selected to serve as a member of Law360’s Mergers & Acquisitions Editorial Advisory Board. Mr. Gruber also presents on developments in corporate and mergers and acquisitions law, having participated in events such as TechGC’s Global Summit.
Mr. Gruber was raised in Newport Beach, California. He received a B.S. summa cum laude from Yale College and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar. He received a J.D. from Stanford Law School, where he was elected to the Order of the Coif.
Mr. Gruber joined Cravath in 2007 and was elected a partner in 2014.
International Bar Association
Law360
The American Lawyer
Bloomberg Law
Chambers USA
IFLR1000
Lawdragon
The Legal 500 US
Euromoney Legal Media Group
Deals & Cases
July 16, 2024
On July 16, 2024, Atalaya Capital Management LP (“Atalaya Capital Management”), a privately‑held alternative credit manager, and Blue Owl Capital Inc. (“Blue Owl Capital”), an alternative asset manager, announced that they have entered into a definitive agreement for Blue Owl Capital to acquire the business of Atalaya Capital Management for $450 million. The closing purchase price of $450 million is comprised of $350 million of Blue Owl equity and $100 million of cash. In addition, there is potential for up to $350 million of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets. Cravath is representing Atalaya Capital Management in connection with the transaction.
Deals & Cases
January 31, 2024
On January 31, 2024, Health Care Service Corporation (“HCSC”), the country’s largest customer‑owned health insurer, announced that it has signed a definitive agreement with The Cigna Group (“Cigna”) to acquire its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies businesses for a purchase price of $3.3 billion. Cigna’s Medicare plans currently serve 3.6 million Medicare members. Cravath is representing HCSC in connection with the transaction.
Deals & Cases
October 16, 2023
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Deals & Cases
August 08, 2023
On August 8, 2023, EchoStar Corporation and DISH Network Corporation (“DISH Network”) announced they have entered into a definitive agreement for DISH Network to combine with EchoStar Corporation in an approximately $6 billion all-stock merger. Cravath is representing the Special Committee of the Board of Directors of EchoStar Corporation in connection with the transaction.
Activities & Publications
October 24, 2023
On October 20, 2023, Cravath prepared a memo for its clients entitled “SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted final rule amendments to modernize beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934. The memo outlines the final rule amendments’ changes and guidance related to deadlines and cut‑off times for Schedule 13D and Schedule 13G filings, structured data language, the application of Regulation 13D-G to certain derivative securities and the definition of “group” in existing statutory language.
Activities & Publications
November 04, 2022
On November 3, 2022, Cravath partners Aaron M. Gruber and Michael L. Arnold participated in TechGC’s 2022 Global Summit, which was held from November 3‑4, 2022 in New York. Aaron co‑led a roundtable entitled “Interacting with Private Equity Sponsors,” which examined the latest developments in the private equity industry and best practices for interacting with private equity sponsors and preparing for private equity transactions. Michael co‑led a roundtable entitled “Public Company: ESG Best Practices,” which explored best practices in ESG including board supervision and related fiduciary duties, data management and reporting, and mandatory and voluntary ESG disclosure regimes.
Aaron M. Gruber is Co-Head of the Global Mergers and Acquisitions Practice. He focuses his practice on mergers and acquisitions, activist defense, corporate governance and general corporate matters.
Mr. Gruber’s clients have included Alcoa, Assisted Living Concepts, Barrick Gold, BDT, Biogen, Biovail Pharmaceuticals, Cigna, Corteva, Cowen, Deutsche Börse, Element Financial, Eurazeo, FS Investments, KION Group, Knorr‑Bremse, The Linde Group, Novartis, NRG Energy, RELX Group, RWE, Ulta Beauty, Unilever, Viatris and Vista Outdoor.
Notable transactions include representing:
Mr. Gruber has been recognized for his work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000 and Lawdragon and has also been recognized by The Legal 500 US for his transactional work in the technology industry. He was named to Bloomberg Law’s “40 Under 40” list in 2022 and was named a “Dealmaker of the Year” by The American Lawyer magazine in 2018. In 2019, he received Euromoney Legal Media Group’s Americas Rising Star Award for “Best in Mergers & Acquisitions,” as well as a “Deal of the Year” award in recognition of his work on behalf of Linde in its $70 billion merger of equals with Praxair. Mr. Gruber’s work on this transaction was also featured by the Financial Times in its annual FT North America Innovative Lawyers 2018 report. In 2018 and 2019, he was selected to serve as a member of Law360’s Mergers & Acquisitions Editorial Advisory Board. Mr. Gruber also presents on developments in corporate and mergers and acquisitions law, having participated in events such as TechGC’s Global Summit.
Mr. Gruber was raised in Newport Beach, California. He received a B.S. summa cum laude from Yale College and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar. He received a J.D. from Stanford Law School, where he was elected to the Order of the Coif.
Mr. Gruber joined Cravath in 2007 and was elected a partner in 2014.
Notable transactions include representing:
Mr. Gruber has been recognized for his work in mergers and acquisitions by Chambers USA, The Legal 500 US, IFLR1000 and Lawdragon and has also been recognized by The Legal 500 US for his transactional work in the technology industry. He was named to Bloomberg Law’s “40 Under 40” list in 2022 and was named a “Dealmaker of the Year” by The American Lawyer magazine in 2018. In 2019, he received Euromoney Legal Media Group’s Americas Rising Star Award for “Best in Mergers & Acquisitions,” as well as a “Deal of the Year” award in recognition of his work on behalf of Linde in its $70 billion merger of equals with Praxair. Mr. Gruber’s work on this transaction was also featured by the Financial Times in its annual FT North America Innovative Lawyers 2018 report. In 2018 and 2019, he was selected to serve as a member of Law360’s Mergers & Acquisitions Editorial Advisory Board. Mr. Gruber also presents on developments in corporate and mergers and acquisitions law, having participated in events such as TechGC’s Global Summit.
Mr. Gruber was raised in Newport Beach, California. He received a B.S. summa cum laude from Yale College and an M.Phil. from the University of Cambridge, where he was a Gates Cambridge Scholar. He received a J.D. from Stanford Law School, where he was elected to the Order of the Coif.
Mr. Gruber joined Cravath in 2007 and was elected a partner in 2014.
International Bar Association
Law360
The American Lawyer
Bloomberg Law
Chambers USA
IFLR1000
Lawdragon
The Legal 500 US
Euromoney Legal Media Group
Deals & Cases
July 16, 2024
On July 16, 2024, Atalaya Capital Management LP (“Atalaya Capital Management”), a privately‑held alternative credit manager, and Blue Owl Capital Inc. (“Blue Owl Capital”), an alternative asset manager, announced that they have entered into a definitive agreement for Blue Owl Capital to acquire the business of Atalaya Capital Management for $450 million. The closing purchase price of $450 million is comprised of $350 million of Blue Owl equity and $100 million of cash. In addition, there is potential for up to $350 million of earnout consideration in the form of equity, subject to certain adjustments and achievement of future revenue targets. Cravath is representing Atalaya Capital Management in connection with the transaction.
Deals & Cases
January 31, 2024
On January 31, 2024, Health Care Service Corporation (“HCSC”), the country’s largest customer‑owned health insurer, announced that it has signed a definitive agreement with The Cigna Group (“Cigna”) to acquire its Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies businesses for a purchase price of $3.3 billion. Cigna’s Medicare plans currently serve 3.6 million Medicare members. Cravath is representing HCSC in connection with the transaction.
Deals & Cases
October 16, 2023
On October 16, 2023, Vista Outdoor Inc. (“Vista Outdoor”), the parent company of 41 renowned brands that design, manufacture and market sporting and outdoor products to consumers around the globe, announced a definitive agreement to sell its Sporting Products business to Czechoslovak Group a.s. (“CSG”), a leading industrial technology holding company, for an enterprise value of $1.91 billion in an all-cash transaction. This transaction represents the next step in Vista Outdoor’s plan to split the company into separate entities. Cravath is representing Vista Outdoor in connection with the transaction.
Deals & Cases
October 02, 2023
On October 1, 2023, Viatris Inc. (“Viatris”), a global healthcare company, announced it has received an offer for the divestiture of substantially all of its Over-the-Counter (“OTC”) business, and has entered into definitive agreements to divest its Women’s Healthcare business, its Active Pharmaceutical Ingredient (“API”) business in India and commercialization rights in certain non-core markets that were acquired as part of the combination with Upjohn. The total transactions value, including Viatris’s 2022 divestiture of its biosimilars business, represents up to $6.94 billion of total gross proceeds. The estimated transaction value for the divestitures announced today is $3.6 billion, including gross consideration of up to approximately $2.17 billion for the divestiture of substantially all of its OTC business, and up to approximately $1.2 billion combined for the divestitures of its API and Women’s Healthcare businesses. Cravath is representing Viatris in connection with the transactions.
Deals & Cases
August 08, 2023
On August 8, 2023, EchoStar Corporation and DISH Network Corporation (“DISH Network”) announced they have entered into a definitive agreement for DISH Network to combine with EchoStar Corporation in an approximately $6 billion all-stock merger. Cravath is representing the Special Committee of the Board of Directors of EchoStar Corporation in connection with the transaction.
Activities & Publications
October 24, 2023
On October 20, 2023, Cravath prepared a memo for its clients entitled “SEC Adopts Rule Amendments To Modernize Beneficial Ownership Reporting.” The memo examines the U.S. Securities and Exchange Commission’s recently adopted final rule amendments to modernize beneficial ownership reporting under Sections 13(d) and 13(g) of the Securities Exchange Act of 1934. The memo outlines the final rule amendments’ changes and guidance related to deadlines and cut‑off times for Schedule 13D and Schedule 13G filings, structured data language, the application of Regulation 13D-G to certain derivative securities and the definition of “group” in existing statutory language.
Activities & Publications
November 04, 2022
On November 3, 2022, Cravath partners Aaron M. Gruber and Michael L. Arnold participated in TechGC’s 2022 Global Summit, which was held from November 3‑4, 2022 in New York. Aaron co‑led a roundtable entitled “Interacting with Private Equity Sponsors,” which examined the latest developments in the private equity industry and best practices for interacting with private equity sponsors and preparing for private equity transactions. Michael co‑led a roundtable entitled “Public Company: ESG Best Practices,” which explored best practices in ESG including board supervision and related fiduciary duties, data management and reporting, and mandatory and voluntary ESG disclosure regimes.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.